Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PAREXEL Expands Data-Driven Monitoring Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

PAREXEL Expands Data-Driven Monitoring Platform

Aims to enhance oversight and control of site-related risk, quality, and performance

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL expanded its Perceptive MyTrials Data-Driven Monitoring (DDM) solution with next generation risk-based monitoring capabilities allowing clients to perform cross-study analysis of quality, risk, and monitoring work effort by combining analytics, reporting and monitoring activity into a single solution.The enhancement aims to increase a drug developer’s ability to demonstrate oversight and control of site-related risk, quality, and performance.

“Centralized monitoring methods are being encouraged by the U.S. Food and Drug Administration (FDA) and other regulatory bodies. By combining our DDM and monitoring solution, PAREXEL clients now have the ability to bridge real-time information gaps between centralized analysts and in-the-field monitoring teams, reducing risk, ensuring documentation, and increasing quality,” said Drew Garty, senior director, product management, PAREXEL.

The Perceptive MyTrials Data-Driven Monitoring solution uses an algorithmic-based approach to clinical monitoring to determine risk and monitor workload, with the goal of enabling flexible and scalable decision-making.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters